当前位置: 首页 > 详情页

Synthesis, antimycobacterial and antibacterial evaluation of 1-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Zhengzhou Univ, New Drug Res & Dev Ctr, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China; [2]Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [3]Peking Union Med Coll, Beijing 100050, Peoples R China; [4]Capital Med Univ, Beijing An Zhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China; [5]Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Pharmacol,Beijing Key Lab Drug Resistance TB, Beijing 101149, Peoples R China
出处:
ISSN:

关键词: Fluoroquinolone derivatives Synthesis Antimycobacterial activity Antibacterial activity

摘要:
A series of novel 1-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives 9a-d containing an oxime functional moiety were synthesized and evaluated for their biological activity. Our results reveal that 9a1 and 9b3 have good in vitro activity against MTB H37Rv ATCC 27294 (MIC: 0.25 mu g/mL) and two MDR-MTB clinical isolates (MICs: 0.065-0.125 mu g/mL). Most of 9a-d show potent activity against Escherichia coli and Klebsiella pneumoniae (MICs: <0.008-4 mu g/mL) except extended-spectrum beta-lactamase-producing strains. Especially, 9a1 and 9d4 possessing excellent in vitro activity against all of the fourteen Gram-positive strains including MRSA and MRSE (MICs: <0.008-2 mu g/mL) comparable to or better than the four reference drugs, show considerable in vivo efficacy against five Gram-negative and Gram-positive isolate strains (ED(50)s: 11.43-26.04 mg/kg). (C) 2014 Elsevier Masson SAS. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 3 区 化学
小类 | 2 区 药物化学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 药物化学
JCR分区:
出版当年[2012]版:
Q1 CHEMISTRY, MEDICINAL
最新[2023]版:
Q1 CHEMISTRY, MEDICINAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Zhengzhou Univ, New Drug Res & Dev Ctr, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China;
通讯作者:
通讯机构: [2]Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [3]Peking Union Med Coll, Beijing 100050, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17070 今日访问量:0 总访问量:919 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院